Lurasidone versus placebo for schizophrenia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lurasidone versus placebo for schizophrenia

Published:2013-03-28 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Donnelly Lorna¹,Sampson Stephanie²

Affiliation:

1. Norfolk and Suffolk Foundation Trust; Acute Psychiatric Services; Wedgewood House, West Suffolk Hospital Hardwick Lane Bury St Edmunds Suffolk UK IP332QZ

2. The University of Nottingham; Cochrane Schizophrenia Group; Sir Colin Campbell Building University of Nottingham Innovation Park, Jubilee Campus Nottingham UK NG7 2TU

Publisher

Wiley

Subject

Pharmacology (medical)

Reference32 articles.

1. Detecting skewness from summary information;Altman;BMJ,1996

2. Statistics notes. Trials randomised in clusters;Bland;BMJ,1997

3. The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use;Boissel;Therapie,1999

4. What causes the onset of psychosis?;Broome;Schizophrenia Research,2005

5. Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychotic;Citrome;International Journal of Clinical Practise,February 2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP